Approval · Notice of Compliance 24519 · 2020
ADVANTAGE MULTI 9: Notice of Compliance 24519
Issued October 28, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24519
- Date
- October 28, 2020
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in producct ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVANTAGE MULTI 9 | 02263505 | Marketed |
Medicinal ingredients
- MOXIDECTIN 4 MG per 0.4ML
- IMIDACLOPRID 40 MG per 0.4ML